Table 2.
n | Heart Rate, beats/min | EDP, mmHg | SP, mmHg | (+)dP/dt, mmHg/s | (−)dP/dt, mmHg/s | Tau, ms | PDP, mmHg | |
---|---|---|---|---|---|---|---|---|
SHAM | 10 | 286 ± 7 | 6 ± 1 | 140 ± 4 | 7,612 ± 299 | −7,554 ± 242 | 18.6 ± 0.5 | 180 ± 5 |
HF-6 wk | 20 | 248 ± 5* | 25 ± 2* | 110 ± 4* | 4,477 ± 251* | −3,031 ± 202* | 31.7 ± 2.3* | 121 ± 8* |
HF-10 wk | 12 | 246 ± 5* | 22 ± 2* | 122 ± 6* | 5,084 ± 308* | −3204 ± 381* | 34.1 ± 2.2* | 129 ± 7* |
Summary of the invasive hemodynamic results (means ±SE; n = number of rats in sample size) from SHAM rats, 6-wk heart failure (HF) rats, and 10-wk HF rats. Hemodynamic data were collected at the terminal procedure, immediately before electrophysiologic assessment. EDP, left ventricular end-diastolic pressure; SP, left ventricular systolic pressure; (+)/(−)dP/dt, positive/negative change in ventricular pressure with respect to time; Tau, left ventricular relaxation time constant; PDP, left ventricular peak developed pressure. While overt differences are seen between SHAM and 6-wk HF (*P < 0.05, ANOVA-Tukey’s honestly significant difference or Kruskal-Wallis ANOVA on ranks and Dunn’s Method), as well as between SHAM and 10-wk HF (*P < 0.05), no differences are observed between 6-wk HF and 10-wk HF.